Abpro Holdings, Inc. (ABPO)
0.41
+0.01
(+3.64%)
USD |
OTCM |
Sep 25, 16:00
Abpro Holdings Enterprise Value : -1.099M for Sept. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 25, 2026 | -1.099M |
| September 24, 2026 | -1.184M |
| September 23, 2026 | -1.187M |
| September 22, 2026 | -1.040M |
| September 21, 2026 | -1.452M |
| September 18, 2026 | -1.217M |
| September 17, 2026 | -1.158M |
| September 16, 2026 | -1.305M |
| September 15, 2026 | -1.924M |
| September 14, 2026 | -2.381M |
| September 11, 2026 | -2.371M |
| September 10, 2026 | -2.317M |
| September 09, 2026 | -2.137M |
| September 08, 2026 | -2.219M |
| September 04, 2026 | -2.164M |
| September 03, 2026 | -2.164M |
| September 02, 2026 | -2.219M |
| September 01, 2026 | -2.219M |
| August 31, 2026 | -2.076M |
| August 28, 2026 | -2.122M |
| August 27, 2026 | -2.155M |
| August 26, 2026 | -2.190M |
| August 25, 2026 | -2.135M |
| August 24, 2026 | -2.373M |
| August 21, 2026 | -2.373M |
| Date | Value |
|---|---|
| August 20, 2026 | -2.324M |
| August 19, 2026 | -2.228M |
| August 18, 2026 | -2.228M |
| August 17, 2026 | -2.290M |
| August 14, 2026 | -2.254M |
| August 13, 2026 | -2.228M |
| August 12, 2026 | -2.228M |
| August 11, 2026 | -2.207M |
| August 10, 2026 | -2.046M |
| August 07, 2026 | -2.042M |
| August 06, 2026 | -2.278M |
| August 05, 2026 | -2.180M |
| August 04, 2026 | -2.171M |
| August 03, 2026 | -1.971M |
| July 31, 2026 | -2.278M |
| July 30, 2026 | -2.278M |
| July 29, 2026 | -2.311M |
| July 28, 2026 | -2.307M |
| July 27, 2026 | -2.369M |
| July 24, 2026 | -2.312M |
| July 23, 2026 | -2.307M |
| July 22, 2026 | -2.307M |
| July 21, 2026 | -2.370M |
| July 20, 2026 | -2.356M |
| July 17, 2026 | -2.230M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.677B |
| Alnylam Pharmaceuticals, Inc. | 33.91B |
| Anika Therapeutics, Inc. | 259.45M |
| Savara, Inc. | 884.37M |
| Vericel Corp. | 1.964B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.94M |
| Total Expenses (Quarterly) | 0.94M |
| EPS Diluted (Quarterly) | -0.1594 |
| Earnings Yield | 253.6% |
| Normalized Earnings Yield | -224.68 |